The bioeconomy – where feedstocks from agriculture are transformed into new products – is poised to surge to more than $30 trillion dollars over the next two decades. The White House calls its potential “enormous,” and there’s an organization leading the effort to create infrastructure around this opportunity. Today, BioMADE Chief Technology Officer, Melanie Tomczak, joins us to tell us 1) what exactly the bioeconomy is, 2) the role of BioMADE in its growth and 3) the unique connection between people, plants and animals.  

Where are the greatest opportunities for growth in bioinnovation? Melanie talks cross-sector collaboration and pushing things from early-scale to commercial scale – getting entrepreneurs out of the “Valley of Death.” She also gets into creating resilience and sustainability in U.S. supply chains in a post-pandemic world also experiencing political unrest and geo instability.  

What’s ahead? BioMADE recently named six states (Indiana being one) to a short list of geographies that could fill a need that doesn’t exist in the US today: allowing innovators to start the scale-up process without the investment into new facilities, allowing for emerging technologies and products to flow through the U.S. more quickly.